Misonix, Inc. (NASDAQ:MSON) Director Thomas M. Patton purchased 5,000 shares of Misonix stock in a transaction that occurred on Wednesday, February 14th. The stock was acquired at an average price of $10.20 per share, for a total transaction of $51,000.00. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website.
Shares of Misonix, Inc. (NASDAQ MSON) traded down $0.01 on Thursday, reaching $10.19. 12,000 shares of the company traded hands, compared to its average volume of 9,072. Misonix, Inc. has a 12 month low of $7.05 and a 12 month high of $12.00.
A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Jefferies Group LLC bought a new stake in Misonix in the fourth quarter worth $160,000. Renaissance Technologies LLC increased its position in Misonix by 4.4% in the fourth quarter. Renaissance Technologies LLC now owns 177,400 shares of the medical equipment provider’s stock worth $1,676,000 after purchasing an additional 7,500 shares during the last quarter. Keybank National Association OH bought a new stake in Misonix in the fourth quarter worth $109,000. Vanguard Group Inc. increased its position in Misonix by 0.9% in the second quarter. Vanguard Group Inc. now owns 106,353 shares of the medical equipment provider’s stock worth $1,027,000 after purchasing an additional 900 shares during the last quarter. Finally, Northern Trust Corp increased its position in Misonix by 2.5% in the second quarter. Northern Trust Corp now owns 24,378 shares of the medical equipment provider’s stock worth $233,000 after purchasing an additional 591 shares during the last quarter. Institutional investors own 10.34% of the company’s stock.
Separately, TheStreet cut shares of Misonix from a “c-” rating to a “d” rating in a research report on Friday, February 9th.
COPYRIGHT VIOLATION NOTICE: This piece was posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece on another website, it was stolen and republished in violation of United States & international copyright legislation. The legal version of this piece can be accessed at https://www.dispatchtribunal.com/2018/02/15/insider-buying-misonix-inc-mson-director-buys-5000-shares-of-stock.html.
Misonix, Inc designs, manufactures, develops and markets minimally invasive therapeutic ultrasonic medical devices. The Company’s products include BoneScalpel surgical system (BoneScalpel), SonaStar Surgical Aspirator (SonaStar), and SonicOne Wound Cleansing and Debridement System (SonicOne). These devices primarily serve the neurosurgery, orthopedic surgery, plastic surgery, wounds, burn and maxillo-facial clinical specialties.
Receive News & Ratings for Misonix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Misonix and related companies with MarketBeat.com's FREE daily email newsletter.